These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 9038158)
1. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158 [TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265 [TBL] [Abstract][Full Text] [Related]
3. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells. Kim YI; Park S; Jeoung DI; Lee H Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952 [TBL] [Abstract][Full Text] [Related]
4. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213 [TBL] [Abstract][Full Text] [Related]
5. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability. Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772 [TBL] [Abstract][Full Text] [Related]
6. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Wagner PD; Steeg PS; Vu ND Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9000-5. PubMed ID: 9256424 [TBL] [Abstract][Full Text] [Related]
8. [The Study on the Phosphorylation Activity of Mutant nm23-H1.]. Yang X; Ma L; Zhu D; Wang D; Wang G; Zhou Q Zhongguo Fei Ai Za Zhi; 2009 Mar; 12(3):193-7. PubMed ID: 20716420 [TBL] [Abstract][Full Text] [Related]
9. Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319. Wagner PD; Vu ND Biochem J; 2000 Mar; 346 Pt 3(Pt 3):623-30. PubMed ID: 10698688 [TBL] [Abstract][Full Text] [Related]
10. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction. Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723 [TBL] [Abstract][Full Text] [Related]
11. Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions. Postel EH; Ferrone CA J Biol Chem; 1994 Mar; 269(12):8627-30. PubMed ID: 8132589 [TBL] [Abstract][Full Text] [Related]
12. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015 [TBL] [Abstract][Full Text] [Related]
13. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity. Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495 [TBL] [Abstract][Full Text] [Related]
14. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells. Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869 [TBL] [Abstract][Full Text] [Related]
15. Protein phosphorylation corrects the folding defect of the neuroblastoma (S120G) mutant of human nucleoside diphosphate kinase A/Nm23-H1. Mocan I; Georgescauld F; Gonin P; Thoraval D; Cervoni L; Giartosio A; Dabernat-Arnaud S; Crouzet M; Lacombe ML; Lascu I Biochem J; 2007 Apr; 403(1):149-56. PubMed ID: 17155928 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity. Lee HY; Lee H Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775 [TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; RaschellĂ G Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679 [TBL] [Abstract][Full Text] [Related]
19. Glyceraldehyde-3-phosphate dehydrogenase and Nm23-H1/nucleoside diphosphate kinase A. Two old enzymes combine for the novel Nm23 protein phosphotransferase function. Engel M; Seifert M; Theisinger B; Seyfert U; Welter C J Biol Chem; 1998 Aug; 273(32):20058-65. PubMed ID: 9685345 [TBL] [Abstract][Full Text] [Related]
20. A novel physical and functional association between nucleoside diphosphate kinase A and AMP-activated protein kinase alpha1 in liver and lung. Crawford RM; Treharne KJ; Best OG; Muimo R; Riemen CE; Mehta A Biochem J; 2005 Nov; 392(Pt 1):201-9. PubMed ID: 16026327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]